Company Diamyd Medical AB Nasdaq Stockholm
Equities
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- SEK | - |
Business Summary
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 0 | 4,970,500 | 0 | 0 | 68.13 % |
Stock B | 1 | 1,437,876 | 0 | 0 | |
Stock C | 0 | 13,701,726 | 13,701,726 ( 100.00 %) | 0 |
Company contact information
Sector
1st Jan change | Capi. | |
---|---|---|
+1.51% | 42.75B | |
+49.22% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- MERT A Stock
- Stock
- Company Diamyd Medical AB